These proteins included extracellular vesicle interleukin-2 (EV IL2) and cathelicidin antimicrobial protein (CAMP) which were elevated, while immunoglobulin lambda variable 1-47 (IGLV1-47), cartilage acidic protein 1 (CRTAC1), leucine-rich alpha-2-glycoprotein 1 (LRG1), insulin-like growth factor 1 (IGF1), and tubulin alpha-1 (TUBA1) were decreased relative to healthy controls
BPC-157 BPC-157 Each vial contains 10mg of BPC-157, produced to ensure precise composition and batch-to-batch uniformity
2024;23:e13273
This research was enabled in part by support provided by Calcul Qubec and Compute Canada (www.computecanada.ca)
clinician determines final eligibility Who shouldn't apply: Personal or family history of medullary thyroid carcinoma or MEN 2 syndrome, history of pancreatitis, certain severe GI or kidney conditions, pregnancy, or breastfeeding - clinician screens at intake FDA regulatory status as of June 2026: Active enforcement and regulatory change ongoing
